Robert A. Lenz

Companies

• NovaBridge BiosciencesBoard member Mar 18, 2026 to now¹
• LB PHARMACEUTICALS INCBoard member Mar 10, 2026 to now²
• Neumora Therapeutics, Inc.Head of R&D Sep 14, 2023 to now³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• NTNeumora Therapeutics, Inc. NMRA309,092 shares⁴$132.0K at $0.43Feb 18, 2025
• NBNovaBridge Biosciences NBP17,218 shares⁵$22.2K at $1.29Aug 22, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 22, 2026Exercised options 17,218 shares of NovaBridge Biosciences⁵
• Feb 18, 2025Sold 5,614 shares at $1.67 of Neumora Therapeutics, Inc.⁴
• Oct 10, 2024Sold 8,260 shares at $15.09 of Neumora Therapeutics, Inc.⁶
• Oct 9, 2024Sold 5,563 shares at $15.01 of Neumora Therapeutics, Inc.⁶
• Sep 18, 2024Sold 10,676 shares at $12.09 of Neumora Therapeutics, Inc.⁷
• Sep 17, 2024Sold 30,788 shares at $11.81 of Neumora Therapeutics, Inc.⁷
• Sep 12, 2024Sold 32,948 shares at $11.43 of Neumora Therapeutics, Inc.⁸
• Feb 14, 2024Granted 50,000 shares of Neumora Therapeutics, Inc.⁹
• Sep 14, 2023Granted 352,941 shares of Neumora Therapeutics, Inc.¹⁰